innovent biologics
CAR-T Therapy Shows Promising Results Against Myeloma
Innovent Biologics’ CT103A, a promising therapy for tough-to-treat blood cancer, has shown positive results in clinical trials.
China Approves Tyvyt For Hodgkin’s Lymphoma
Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody, was co-discovered by Innovent and Adimab and jointly developed by Innovent and Eli Lilly in China.
